As lipotoxicity appears to be the central driver in NASH progression by oxidative stress and ER stress (69), lipotoxic activation of TBK1, a downstream of cGAS-STING kinase, is also crucial for the control of the NASH development (70). Here, STING1 is linked to metabolic dysfunction-associated steatohepatitis.